IL163513A0 - A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereof - Google Patents
A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereofInfo
- Publication number
- IL163513A0 IL163513A0 IL16351399A IL16351399A IL163513A0 IL 163513 A0 IL163513 A0 IL 163513A0 IL 16351399 A IL16351399 A IL 16351399A IL 16351399 A IL16351399 A IL 16351399A IL 163513 A0 IL163513 A0 IL 163513A0
- Authority
- IL
- Israel
- Prior art keywords
- enzymepolypeptidein
- thepreparation
- tnf
- converting
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7370998P | 1998-02-04 | 1998-02-04 | |
| US5008398A | 1998-03-30 | 1998-03-30 | |
| US11747699P | 1999-01-27 | 1999-01-27 | |
| PCT/US1999/002185 WO1999040182A2 (en) | 1998-02-04 | 1999-02-03 | CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163513A0 true IL163513A0 (en) | 2005-12-18 |
Family
ID=27367666
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13755799A IL137557A0 (en) | 1998-02-04 | 1999-02-03 | A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same |
| IL16351399A IL163513A0 (en) | 1998-02-04 | 1999-02-03 | A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereof |
| IL163513A IL163513A (en) | 1998-02-04 | 2004-08-12 | Composition containing a tnf- 2 - converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13755799A IL137557A0 (en) | 1998-02-04 | 1999-02-03 | A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL163513A IL163513A (en) | 1998-02-04 | 2004-08-12 | Composition containing a tnf- 2 - converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1053304B1 (xx) |
| JP (1) | JP2004503202A (xx) |
| CN (1) | CN1342200A (xx) |
| AR (2) | AR015513A1 (xx) |
| AT (1) | ATE366303T1 (xx) |
| AU (1) | AU2574099A (xx) |
| CA (1) | CA2319040A1 (xx) |
| DE (1) | DE69936445T2 (xx) |
| DK (1) | DK1053304T3 (xx) |
| ES (1) | ES2293718T3 (xx) |
| HU (1) | HUP0101596A1 (xx) |
| IL (3) | IL137557A0 (xx) |
| NO (1) | NO20003687L (xx) |
| NZ (1) | NZ505959A (xx) |
| WO (1) | WO1999040182A2 (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406901B1 (en) | 1995-06-08 | 2002-06-18 | Immunex Corporation | TNF-a converting enzyme |
| AU2002233916A1 (en) * | 2000-08-03 | 2002-04-29 | Albert Einstein College Of Medicine | Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection |
| US7138264B1 (en) * | 2002-05-24 | 2006-11-21 | Schering Corporation | Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof |
| WO2005073400A2 (en) * | 2004-01-26 | 2005-08-11 | University Of Massachusetts | Method of identifying amp- activated protein kinase (ampk) modulators and uses therefor |
| TWI516274B (zh) * | 2013-11-27 | 2016-01-11 | 財團法人工業技術研究院 | 應用於生髮之方法及醫藥組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
| US5702935A (en) * | 1994-04-28 | 1997-12-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method and compounds for inhibiting lipid biosynthesis of bacteria and plants |
| EP0830130B9 (en) * | 1995-06-08 | 2004-12-29 | Immunex Corporation | Tnf-alpha converting enzyme |
| AU6960696A (en) * | 1995-08-30 | 1997-03-19 | Ariad Pharmaceuticals, Inc. | Crystalline zap family proteins |
| AU1115797A (en) * | 1995-10-26 | 1997-05-15 | Alessandra D'azzo | Protective protein/cathepsin a and precursor: crystallization, x-ray diffraction, three-dimensional structure determination and rational drug design |
| CA2249985A1 (en) * | 1996-03-26 | 1997-10-02 | Glaxo Group Limited | Tumour necrosis factor alpha convertase |
-
1999
- 1999-02-03 AT AT99905615T patent/ATE366303T1/de not_active IP Right Cessation
- 1999-02-03 WO PCT/US1999/002185 patent/WO1999040182A2/en active IP Right Grant
- 1999-02-03 CN CN99804893.3A patent/CN1342200A/zh active Pending
- 1999-02-03 ES ES99905615T patent/ES2293718T3/es not_active Expired - Lifetime
- 1999-02-03 AU AU25740/99A patent/AU2574099A/en not_active Abandoned
- 1999-02-03 IL IL13755799A patent/IL137557A0/xx not_active IP Right Cessation
- 1999-02-03 DE DE69936445T patent/DE69936445T2/de not_active Expired - Fee Related
- 1999-02-03 NZ NZ505959A patent/NZ505959A/en unknown
- 1999-02-03 JP JP2000530596A patent/JP2004503202A/ja active Pending
- 1999-02-03 CA CA002319040A patent/CA2319040A1/en not_active Abandoned
- 1999-02-03 DK DK99905615T patent/DK1053304T3/da active
- 1999-02-03 HU HU0101596A patent/HUP0101596A1/hu unknown
- 1999-02-03 IL IL16351399A patent/IL163513A0/xx active IP Right Grant
- 1999-02-03 EP EP99905615A patent/EP1053304B1/en not_active Expired - Lifetime
- 1999-02-04 AR ARP990100476A patent/AR015513A1/es not_active Application Discontinuation
-
2000
- 2000-07-18 NO NO20003687A patent/NO20003687L/no not_active Application Discontinuation
- 2000-07-19 AR ARP000103727A patent/AR024804A1/es unknown
-
2004
- 2004-08-12 IL IL163513A patent/IL163513A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20003687D0 (no) | 2000-07-18 |
| DK1053304T3 (da) | 2007-11-05 |
| CA2319040A1 (en) | 1999-08-12 |
| DE69936445D1 (de) | 2007-08-16 |
| ES2293718T3 (es) | 2008-03-16 |
| AR015513A1 (es) | 2001-05-02 |
| NO20003687L (no) | 2000-09-19 |
| EP1053304A2 (en) | 2000-11-22 |
| DE69936445T2 (de) | 2008-04-10 |
| ATE366303T1 (de) | 2007-07-15 |
| AR024804A1 (es) | 2002-10-23 |
| JP2004503202A (ja) | 2004-02-05 |
| EP1053304B1 (en) | 2007-07-04 |
| CN1342200A (zh) | 2002-03-27 |
| AU2574099A (en) | 1999-08-23 |
| IL163513A (en) | 2007-03-08 |
| IL137557A0 (en) | 2001-07-24 |
| NZ505959A (en) | 2003-05-30 |
| WO1999040182A3 (en) | 1999-10-07 |
| HUP0101596A1 (hu) | 2001-08-28 |
| WO1999040182A2 (en) | 1999-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1017854A1 (en) | Oral composition | |
| HUP0004615A3 (en) | Polypropylene composition useful for making solid state oriented film | |
| EP1016400A4 (en) | COMPOSITION FOR EXTERNAL USE | |
| IL139210A (en) | Pharmaceutical composition containing a macrolide compound | |
| PT1466615E (pt) | Composição farmacêutica | |
| GB9809058D0 (en) | Composition | |
| AU4143999A (en) | Oral composition comprising capsules | |
| HUP0202255A2 (en) | Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them | |
| GB2345290B (en) | Polypropylene composition | |
| PL343769A1 (en) | Pharmaceutical composition | |
| HUP0204069A3 (en) | Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it | |
| GB9812119D0 (en) | Composition | |
| SG111981A1 (en) | Crystalline efavirenz | |
| EG22705A (en) | Pesticidal composition | |
| GB9827894D0 (en) | Composition | |
| IL163513A0 (en) | A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereof | |
| EP1124557A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB9816252D0 (en) | Molluscicidal composition | |
| AU4910199A (en) | Oral composition | |
| GB9903310D0 (en) | Composition | |
| PL346769A1 (en) | A new composition | |
| GB9816039D0 (en) | Molluscicidal composition | |
| GB9916754D0 (en) | A composition | |
| PL346763A1 (en) | A new composition | |
| HU9800078D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |